Evidence mapPaperPMID 41599589Full record

ArticlePolymers2026

Polylactide/Polycaprolactone Nanofiber Scaffold Enhances Primary Cortical Neuron Growth.

Valeriia S Shtol, Anastasiia D Tsareva, Kirill A Arsentiev, Sophia P Konovalova, Suanda A Tlimahova, Dmitry V Klinov, Dimitri A Ivanov, Pavel E Musienko

Abstract read
In one paragraph

Article in Polymers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Valeriia S ShtolScientific Center for Genetics and Life Sciences, Sirius University of Science and Technology, 1, Olympic Ave., 354340 Sochi, Russia.ORCID 0009-0005-9999-4176
Anastasiia D TsarevaScientific Center for Genetics and Life Sciences, Sirius University of Science and Technology, 1, Olympic Ave., 354340 Sochi, Russia.ORCID 0009-0001-3171-815X
Kirill A ArsentievScientific Center for Genetics and Life Sciences, Sirius University of Science and Technology, 1, Olympic Ave., 354340 Sochi, Russia.
Sophia P KonovalovaScientific Center for Genetics and Life Sciences, Sirius University of Science and Technology, 1, Olympic Ave., 354340 Sochi, Russia.ORCID 0000-0002-5393-3571
Suanda A TlimahovaScientific Center for Genetics and Life Sciences, Sirius University of Science and Technology, 1, Olympic Ave., 354340 Sochi, Russia.
Dmitry V KlinovScientific Center for Genetics and Life Sciences, Sirius University of Science and Technology, 1, Olympic Ave., 354340 Sochi, Russia.
Dimitri A IvanovScientific Center for Genetics and Life Sciences, Sirius University of Science and Technology, 1, Olympic Ave., 354340 Sochi, Russia.ORCID 0000-0002-5905-2652
Pavel E MusienkoScientific Center for Genetics and Life Sciences, Sirius University of Science and Technology, 1, Olympic Ave., 354340 Sochi, Russia.

Funding

«Sirius» Federal Territory» Agreement № 18-03 date 10.09.2024
6 · The paper itself

Abstract

Spinal cord injury (SCI) remains a major clinical challenge due to the limited regenerative capacity of the central nervous system (CNS). Effective scaffolds for repair must combine mechanical compatibility with host tissue, controlled degradation matching the time course of regeneration, and microarchitectural features that promote neuronal survival. Electrospun nanofibrous scaffolds mimic the structural and mechanical features of the extracellular matrix, providing critical cues for neuronal adhesion and glial modulation in neural regeneration. Here, we fabricated biodegradable poly(lactic acid)/poly(ε-caprolactone) (PLA/PCL) scaffolds using a dichloromethane/tetrahydrofuran (DCM/THF) solvent system to induce surface porosity via solvent-driven phase separation. The DCM/THF solvent system formulation produced nanofibers with porous surfaces and increased area for cell interaction. PLA/PCL scaffolds showed a Young's modulus of ~26 MPa and sustained degradation, particularly under oxidative conditions simulating the post-injury microenvironment. In vitro, these scaffolds enhanced neuronal density up to fivefold and maintained ~80% viability over 10 days in primary neuron-glia cultures. Morphometric analysis revealed that DCM/THF-based scaffolds supported astrocytes with preserved process complexity and reduced circularity, indicative of a less reactive morphology. In contrast, scaffolds fabricated with 1,1,1,3,3,3-hexafluoro-2-propanol (HFIP) displayed reduced bioactivity and promoted morphological features associated with astrocyte reactivity, including cell rounding and process retraction. These findings demonstrate that solvent-driven control of scaffold microarchitecture is a powerful strategy to enhance neuronal integration and modulate glial morphology, positioning DCM/THF-processed PLA/PCL scaffolds as a promising platform for CNS tissue engineering.

Indexed as

biodegradable scaffoldscell therapyelectrospinningneural tissue engineeringpolycaprolactonepoly(lactic acid)polymer matrixporous nanofibersspinal cord injury

Identifiers

PMID41599589
PMCPMC12845921

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.